Snowden Capital Advisors’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-11,405
| Closed | -$497K | – | 1144 |
|
|
2023
Q3 | $497K | Buy |
11,405
+4,075
| +56% | +$178K | 0.02% | 659 |
|
|
2023
Q2 | $265K | Sell |
7,330
-16
| -0.2% | -$578 | 0.01% | 1002 |
|
|
2023
Q1 | $273K | Buy |
7,346
+244
| +3% | +$9.07K | 0.01% | 974 |
|
|
2022
Q4 | $322K | Buy |
7,102
+1,840
| +35% | +$83.4K | 0.01% | 893 |
|
|
2022
Q3 | $367K | Buy |
5,262
+1,813
| +53% | +$126K | 0.02% | 795 |
|
|
2022
Q2 | $231K | Buy |
+3,449
| New | +$231K | 0.01% | 981 |
|
|
2022
Q1 | – | Sell |
-550
| Closed | -$80K | – | 2161 |
|
|
2021
Q4 | $80K | Buy |
+550
| New | +$80K | ﹤0.01% | 910 |
|